Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam vs Prednisolone Premedication for Post-Endodontic Pain
NCT07281807Phase 4Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of piroxicam in irreversible pulpitis and apical periodontitis (AP) (2 arms). Primary endpoint: Post-operative pain score at 48 hours. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
piroxicam
03
Conditions
irreversible pulpitisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT07281807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07281807.